Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on July 27, 2009

Circulation. 2009
Published online before print July 27, 2009, doi: 10.1161/CIRCULATIONAHA.108.838821
A more recent version of this article appeared on August 11, 2009
This Article
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Circulation: August 11, 2009, Volume 120, Number 6
Right arrow All Versions of this Article:
120/6/477    most recent
CIRCULATIONAHA.108.838821v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jain, R.
Right arrow Articles by Calkins, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jain, R.
Right arrow Articles by Calkins, H.
Related Collections
Right arrow Other heart failure
Right arrow Electrocardiology
Right arrowRelated Article

Submitted on December 1, 2008
Accepted on June 1, 2009

Electrocardiographic Features of Arrhythmogenic Right Ventricular Dysplasia

Rahul Jain MD, Darshan Dalal MD, Amy Daly MS, Crystal Tichnell MGC, Cynthia James PhD, Ariana Evenson MHSA, Rohit Jain MD, Theodore Abraham MD, Boon Yew Tan MBChB, Hari Tandri MD, Stuart D. Russell MD, Daniel Judge MD, and Hugh Calkins MD*

From the Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Md.

* To whom correspondence should be addressed. E-mail: hcalkins{at}jhmi.edu.

Background—The purpose of this study was to reevaluate the ECG features of arrhythmogenic right ventricular dysplasia (ARVD). The second objective was to evaluate the sensitivity and specificity of the standard and newly proposed diagnostic ECG markers in the presence of a right bundle-branch block (RBBB).

Methods and Results—One hundred patients with ARVD (57 men; aged 39±15 years) and 57 controls (21 men; aged 40±17 years) were included. Among the 100 patients with ARVD, a complete RBBB was present in 17 patients, and 15 patients had an incomplete RBBB. T-wave inversion through V3 demonstrated optimal sensitivity and specificity in both ARVD patients without a complete RBBB or incomplete RBBB (71% [95% confidence interval, 58% to 81%] and 96% [95% confidence interval, 81% to 100%], respectively) and in ARVD patients with incomplete RBBB (73% [95% confidence interval, 45% to 92%] and 95% [95% confidence interval, 77% to 100%], respectively). Between ARVD patients and controls with a complete RBBB, the only 2 parameters that differed were the prevalence of T-wave inversion through V4 (59% versus 12%, respectively; P<0.05) and an r'/s ratio in V1 <1 (88% versus 14%, respectively; P<0.005). In ARVD patients with complete RBBB, the most sensitive and specific parameter was an r'/s ratio <1.

Conclusions—We evaluated comprehensively the diagnostic value of ECG markers for ARVD. On the basis of the findings, we propose an algorithm, with examination of QRS morphology being the first step, for ECG evaluation of ARVD patients. Definite criteria are then applied on the basis of the presence of no RBBB, incomplete RBBB, and complete RBBB to obtain the best diagnostic utility of the ECG.


Key words: arrhythmogenic right ventricular cardiomyopathy • arrhythmogenic right ventricular dysplasia • right bundle-branch block


Related Article:

Clinical Summaries
Circulation 2009 120: 459-460. [Extract] [Full Text]